Regulation and Prequalification
Progress towards enhancing regulatory practices related to medical products around the world is supported by capacity building, promoting regulatory convergence and harmonization.

Publications

All →
Estimation of background rates of adverse events of special interest in neonatal outcomes: preterm births, stillbirths, neonatal deaths and low birthweight

During pregnancy, women and infants are predisposed to specific infections due to various immunological and physiological changes. These infections can...

The global smart 
pharmacovigilance strategy

Trust in regulated medical products (medicines, vaccines and other health products) to protect health, is mostly based on a number of principles: the...

World Local Production Forum on enhancing access to medicines and other health technologies: report of the third meeting, Abu Dhabi, United Arab Emirates, 7–9 April 2025

This report provides an overview of the third WLPF, held from April 7 to 9, 2024, in Abu Dhabi, United Arab Emirates. Organized by the WHO Local Production...

WHO Drug Information - Volume 39, No. 3

The Third issue of volume 39 for 2025 includes:Consultation Documents: Cefiderocol sulfate tosilate (cefiderocoli sulfas tosilatum) Cefiderocol powder...

Related documents

Cover image of the Call for action "Greener pharmaceuticals regulatory highway"
Call for action on regulatory support for introduction of more sustainable products and services

An effective regulatory system plays a critical role in ensuring the quality of health products, spanning from their development in the laboratory to their...

Newsletters

All →
WHO pharmaceuticals newsletter - No. 2, 2025

The WHO pharmaceuticals newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities...

Report of the 48th meeting 
of the WHO Global Advisory 
Committee on Vaccine Safety, 
15–16 May 2025

The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999, and the Advisory Committee on Safety of Medicinal Products (ACSoMP)...